Resource Library

Initiation and Continued Use of Oral Pre-Exposure Prophylaxis among Pregnant and Postpartum Women in South Africa (PrEP-PP): A demonstration cohort study

This article from The Lancet HIV describes the results of a demonstration study in South Africa, PrEP-PP, to integrate oral PrEP provision into public clinics offering antenatal and postnatal care to pregnant and lactating people.

Research, Service Delivery

Acceptability of Six-Monthly PrEP Dispensing Supported with Interim HIV Self-Testing to Simplify PrEP Delivery in Kenya: Findings from qualitative research

This article from BMC Health Services Research discusses the results of a pilot in Kenya to explore the acceptability of dispensing PrEP twice a year, with interim HIV self-testing, versus quarterly, with clinic-based HIV testing.

Research, Service Delivery, Testing

True Choice in HIV Prevention Involves More than Product Options: Novel strategies in service delivery

Video Recording and English Audio / Portuguese Audio / Spanish Audio / Ukrainian Audio / Slides / Resources Join The Choice Agenda and presenters from Brazil, Kenya, and South Africa to discuss novel strategies for the delivery of HIV prevention interventions. All HIV prevention products have their “Achilles Heels.” Differentiated service delivery supports reaching a…

Service Delivery

Applying CFIR to Assess Multi-level Barriers to PrEP Delivery in Rural South Africa: Processes, gaps and opportunities for service delivery of current and future PrEP modalities

This article from Social Science and Medicine uses the Consolidated Framework for Implementation Research (CFIR) to assess the context of PrEP delivery for adolescent girls and young women (AGYW) in rural South Africa and identify the factors supporting and impeding PrEP implementation to develop strategies to improve PrEP delivery.

Research, Service Delivery

Examining Concordance of Sexual-related Factors and PrEP Eligibility with HIV Risk Perception among Adolescent Girls and Young Women: Cross-sectional insights from DREAMS sites in Kenya, Malawi, and Zambia

This article from BMC Public Health examines HIV risk perception of adolescent girls and young women in Kenya, Malawi, and Zambia, including how well it correlates with PrEP eligibility.

Research, Service Delivery

CAB PrEP Introduction Situation Analysis – South Africa – 2024

This document summarizes findings from the national situation analysis that can support the creation of a national biomedical HIV prevention platform.

Dynamic Choice HIV Prevention with Cabotegravir Long-acting Injectable in Rural Uganda and Kenya: A randomised trial extension

This article from The Lancet HIV discusses the results of the SEARCH dynamic choice study conducted in Kenya and Uganda, comparing outcomes between one group offered a choice between oral PrEP, post-exposure prophylaxis, and cabotegravir for PrEP, and a second group receiving the standard of care.

Research, Service Delivery

Adolescent Girls and Young Women Overcoming Adherence Challenges with Vaginal and Oral PrEP Use: A longitudinal qualitative study from a crossover trial in South Africa, Uganda, and Zimbabwe

This article from AIDS and Behavior explores South African, Ugandan, and Zimbabwean adolescent girls and young women’s experiences in a crossover trial of two HIV prevention products: daily oral PrEP and a monthly dapivirine vaginal ring.

Research, Service Delivery

PEP: The Forgotten HIV Prevention

This webinar, hosted by the South to South Learning Network, will explore the latest updates to post-exposure prophylaxis (PEP) guidelines, review the outcomes of a recent PEP meeting that included five countries, and discuss how the updated PEP guidelines can be applied in practice. Participants will learn from country experiences with integrating PEP and PrEP,…

Health Impact, Budget Impact, and Price Threshold for Cost-effectiveness of Lenacapavir for HIV Pre-exposure Prophylaxis in Eastern and Southern Africa: A modelling analysis

This article from The Lancet HIV describes the use of the EMOD-HIV model to estimate the health and budget impacts and threshold price at which lenacapavir for PrEP could be cost-effective in eastern and southern Africa.

Financing & Costing, Research